This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Taipei Medical University, National Taiwan University. Active years: 2009-2025.
Company Filing History:
Years Active: 2009-2025
Title: Innovations of Ching-Li Tseng in Ophthalmic Research
Introduction
Ching-Li Tseng is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of ophthalmology through his innovative research and development of pharmaceutical compositions. With a total of 3 patents, Tseng's work focuses on addressing critical issues related to eye health.
Latest Patents
One of Tseng's latest patents is titled "Self-assembled nanoparticle and use thereof for anti-angiogenesis." This invention provides a nanoparticle or a pharmaceutical composition that treats or remits neovascularization or angiogenesis in eye segments. The nanoparticle includes hyaluronic acid and a therapeutic peptide, and it offers a method for inhibiting the formation or growth of blood vessels by administering the nanoparticle to a subject in need. Another significant patent is the "Lutein-containing ophthalmic composition." This composition consists mainly of a natural anti-inflammatory substance, a substance that increases liquid viscosity, and an artificial tear. The formulation is designed to enhance the retention time of the anti-inflammatory substance on the ocular surface, thereby treating dry eye syndrome and inhibiting ocular surface inflammation.
Career Highlights
Ching-Li Tseng has worked with prestigious institutions such as Taipei Medical University and National Taiwan University. His research has been instrumental in advancing the understanding and treatment of various ocular conditions.
Collaborations
Tseng has collaborated with notable colleagues, including Feng Huei Lin and Chun-Pin Lin, who have contributed to his research endeavors.
Conclusion
Ching-Li Tseng's innovative work in ophthalmic research has led to the development of valuable patents that address significant health issues. His contributions continue to impact the field positively, enhancing treatment options for patients with eye conditions.